Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody

References

• Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980; 56:947-58; PMID:7002232
   PubMed Web of Science ®Google Scholar
• Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994; 91:5592-6; PMID:8202532; http://dx.doi.org/10.1073/pnas.91.12.5592
   PubMed Web of Science ®Google Scholar
• Dranoff G, Mulligan RC. Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies. Stem Cells 1994; 12 Suppl 1:173-82; PMID:7696961
   PubMed Web of Science ®Google Scholar
• Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8:533-44; PMID:18551128; http://dx.doi.org/10.1038/nri2356
   PubMed Web of Science ®Google Scholar
• Cook AD, Braine EL, Campbell IK, Rich MJ, Hamilton JA. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res 2001; 3:293-8; PMID:11549370
   PubMedGoogle Scholar
• Plater-Zyberk C, Joosten LA, Helsen MM, Hepp J, Baeuerle PA, van den Berg WB. GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice. Ann Rheum Dis 2007; 66:452-7; PMID:17020908; http://dx.doi.org/10.1136/ard.2006.057182
   PubMed Web of Science ®Google Scholar
• McQualter JL, Darwiche R, Ewing C, Onuki M, Kay TW, Hamilton JA, Reid HH, Bernard CC. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med 2001; 194:873-82; PMID:11581310; http://dx.doi.org/10.1084/jem.194.7.873
   PubMed Web of Science ®Google Scholar
• Codarri L, Gyulveszi G, Tosevski V, Hesske L, Fontana A, Magnenat L, Suter T, Becher B. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011; 12:560-7; PMID:21516112; http://dx.doi.org/10.1038/ni.2027
   PubMed Web of Science ®Google Scholar
• Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 2009; 5:554-9; PMID:19798030; http://dx.doi.org/10.1038/nrrheum.2009.178
   PubMed Web of Science ®Google Scholar
• Hamilton JA, Tak PP. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 2009; 60:1210-21; PMID:19404968; http://dx.doi.org/10.1002/art.24505
   PubMed Web of Science ®Google Scholar
• Greven DE, Cohen ES, Gerlag DM, Campbell J, Woods J, Davis N, van Nieuwenhuijze A, Lewis A, Heasmen S, McCourt M, et al. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. Ann Rheum Dis 2015; 74:1924-30.
   PubMed Web of Science ®Google Scholar
• Pandit J, Bohm A, Jancarik J, Halenbeck R, Koths K, Kim SH. Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science 1992; 258:1358-62; PMID:1455231; http://dx.doi.org/10.1126/science.1455231
   PubMed Web of Science ®Google Scholar
• Gasson JC, Kaufman SE, Weisbart RH, Tomonaga M, Golde DW. High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. Proc Natl Acad Sci USA 1986; 83:669-73; PMID:3484823; http://dx.doi.org/10.1073/pnas.83.3.669
   PubMed Web of Science ®Google Scholar
• Gearing DP, King JA, Gough NM, Nicola NA. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 1989; 8:3667-76; PMID:2555171
   PubMed Web of Science ®Google Scholar
• Hoang T, De LA, Haman A, Beauchemin V, Kitamura T, Clark SC. The structure and dynamics of the granulocyte macrophage colony-stimulating factor receptor defined by the ternary complex model. J Biol Chem 1993; 268:11881-7; PMID:8505314
   PubMed Web of Science ®Google Scholar
• Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, Powell J, Ramshaw H, Woodcock JM, Xu Y, Guthridge M, et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008; 134:496-507; PMID:18692472; http://dx.doi.org/10.1016/j.cell.2008.05.053
   PubMed Web of Science ®Google Scholar
• Steidl S, Ratsch O, Brocks B, Durr M, Thomassen-Wolf E. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Mol Immunol 2008; 46:135-44; PMID:18722015; http://dx.doi.org/10.1016/j.molimm.2008.07.013
   PubMed Web of Science ®Google Scholar
• Rothe C, Urlinger S, Lohning C, Prassler J, Stark Y, Jager U, Hubner B, Bardroff M, Pradel I, Boss M, et al. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J Mol Biol 2008; 376:1182-200; PMID:18191144; http://dx.doi.org/10.1016/j.jmb.2007.12.018
   PubMed Web of Science ®Google Scholar
• Kabsch W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr D Biol Crystallogr 2010; 66:133-44; PMID:20124693; http://dx.doi.org/10.1107/S0907444909047374
   PubMed Web of Science ®Google Scholar
• Kabsch W. XDS. Acta Crystallogr D Biol Crystallogr 2010; 66:125-32; PMID:20124692; http://dx.doi.org/10.1107/S0907444909047337
   PubMed Web of Science ®Google Scholar
• Vagin A, Teplyakov A. Molecular replacement with MOLREP. Acta Crystallogr D Biol Crystallogr 2010; 66:22-5; PMID:20057045; http://dx.doi.org/10.1107/S0907444909042589
   PubMed Web of Science ®Google Scholar
• Faber C, Shan L, Fan Z, Guddat LW, Furebring C, Ohlin M, Borrebaeck CA, Edmundson AB. Three-dimensional structure of a human Fab with high affinity for tetanus toxoid. Immunotechnology. 1998; 3:253-70; PMID:9530559; http://dx.doi.org/10.1016/S1380-2933(97)10003-3
   PubMedGoogle Scholar
• Rozwarski DA, Diederichs K, Hecht R, Boone T, Karplus PA. Refined crystal structure and mutagenesis of human granulocyte-macrophage colony-stimulating factor. Proteins 1996; 26:304-13; PMID:8953651; http://dx.doi.org/10.1002/(SICI)1097-0134(199611)26:3%3c304::AID-PROT6%3e3.0.CO;2-D
   PubMed Web of Science ®Google Scholar
• Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 2011; 67:235-42; PMID:21460441; http://dx.doi.org/10.1107/S0907444910045749
   PubMed Web of Science ®Google Scholar
• Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60:2126-32; PMID:15572765; http://dx.doi.org/10.1107/S0907444904019158
   PubMed Web of Science ®Google Scholar
• Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997; 53:240-55; PMID:15299926; http://dx.doi.org/10.1107/S0907444996012255
   PubMed Web of Science ®Google Scholar
• Wu TT, Kabat EA. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 1970; 132:211-50; PMID:5508247; http://dx.doi.org/10.1084/jem.132.2.211
   PubMed Web of Science ®Google Scholar
• Narciso JE, Uy ID, Cabang AB, Chavez JF, Pablo JL, Padilla-Concepcion GP, Padlan EA. Analysis of the antibody structure based on high-resolution crystallographic studies. N Biotechnol 2011; 28:435-47; PMID:21477671; http://dx.doi.org/10.1016/j.nbt.2011.03.012
   PubMed Web of Science ®Google Scholar
• Stanfield RL, Gorny MK, Zolla-Pazner S, Wilson IA. Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity. J Virol 2006; 80:6093-105; PMID:16731948; http://dx.doi.org/10.1128/JVI.00205-06
   PubMed Web of Science ®Google Scholar
• Tiller T, Schuster I, Deppe D, Siegers K, Strohner R, Herrmann T, Berenguer M, Poujol D, Stehle J, Stark Y, et al. A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties. MAbs. 2013; 5:445-70; PMID:23571156; http://dx.doi.org/10.4161/mabs.24218
   PubMed Web of Science ®Google Scholar
• Walter MR, Cook WJ, Ealick SE, Nagabhushan TL, Trotta PP, Bugg CE. Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. J Mol Biol 1992; 224:1075-85; PMID:1569568; http://dx.doi.org/10.1016/0022-2836(92)90470-5
   PubMed Web of Science ®Google Scholar
• Sundberg EJ, Urrutia M, Braden BC, Isern J, Tsuchiya D, Fields BA, Malchiodi EL, Tormo J, Schwarz FP, Mariuzza RA. Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. Biochemistry 2000; 39:15375-87; PMID:11112523; http://dx.doi.org/10.1021/bi000704l
   PubMed Web of Science ®Google Scholar
• Sundberg EJ, Mariuzza RA. Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions. Structure. 2000; 8: R137-R142; PMID:10903952; http://dx.doi.org/10.1016/S0969-2126(00)00167-2
   PubMed Web of Science ®Google Scholar
• Reichmann D, Phillip Y, Carmi A, Schreiber G. On the contribution of water-mediated interactions to protein-complex stability. Biochemistry 2008; 47:1051-60; PMID:18161993; http://dx.doi.org/10.1021/bi7019639
   PubMed Web of Science ®Google Scholar
• Cavallo L, Kleinjung J, Fraternali F. POPS: A fast algorithm for solvent accessible surface areas at atomic and residue level. Nucleic Acids Res. 2003; 31:3364-6; PMID:12824328; http://dx.doi.org/10.1093/nar/gkg601
   PubMed Web of Science ®Google Scholar
• Lawrence MC, Colman PM. Shape complementarity at protein/protein interfaces. J Mol Biol 1993; 234:946-50; PMID:8263940; http://dx.doi.org/10.1006/jmbi.1993.1648
   PubMed Web of Science ®Google Scholar
• Jones S, Thornton JM. Principles of protein-protein interactions. Proc Natl Acad Sci USA 1996; 93:13-20; PMID:8552589; http://dx.doi.org/10.1073/pnas.93.1.13
   PubMed Web of Science ®Google Scholar
• Janin J, Wodak SJ. Protein modules and protein-protein interaction. Introduction. Adv Protein Chem 2002; 61:1-8; PMID:12461819; http://dx.doi.org/10.1016/S0065-3233(02)61000-9
   PubMedGoogle Scholar
• Wodak SJ, Janin J. Structural basis of macromolecular recognition. Adv Protein Chem 2002; 61:9-73; PMID:12461820; http://dx.doi.org/10.1016/S0065-3233(02)61001-0
   PubMedGoogle Scholar
• Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I. Analysis and assessment of ab initio three-dimensional prediction, secondary structure, and contacts prediction. Proteins 1999; Suppl 3:149-70; PMID:10526364; http://dx.doi.org/10.1002/(SICI)1097-0134(1999)37:3+%3c149::AID-PROT20%3e3.0.CO;2-H
   PubMedGoogle Scholar
• Sundberg EJ, Andersen PS, Schlievert PM, Karjalainen K, Mariuzza RA. Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation. Structure. 2003; 11:1151-61; PMID:12962633; http://dx.doi.org/10.1016/S0969-2126(03)00187-4
   PubMed Web of Science ®Google Scholar
• Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J Mol Biol 1999; 293:865-81; PMID:10543973; http://dx.doi.org/10.1006/jmbi.1999.3192
   PubMed Web of Science ®Google Scholar
• Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, Lou J, Geren I, Stevens RC, Marks JD. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat Biotechnol 2007; 25:107-16; PMID:17173035; http://dx.doi.org/10.1038/nbt1269
   PubMed Web of Science ®Google Scholar
• Li Y, Li H, Yang F, Smith-Gill SJ, Mariuzza RA. X-ray snapshots of the maturation of an antibody response to a protein antigen. Nat Struct Biol 2003; 10:482-8; PMID:12740607; http://dx.doi.org/10.1038/nsb930
   PubMedGoogle Scholar
• Blech M, Seeliger D, Kistler B, Bauer MM, Hafner M, Horer S, Zeeb M, Nar H, Park JE. Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications. Biochem J 2012; 447:205-15; PMID:22839360; http://dx.doi.org/10.1042/BJ20120884
   PubMed Web of Science ®Google Scholar
• Hercus TR, Cambareri B, Dottore M, Woodcock J, Bagley CJ, Vadas MA, Shannon MF, Lopez AF. Identification of residues in the first and fourth helices of human granulocyte-macrophage colony-stimulating factor involved in biologic activity and in binding to the alpha- and beta-chains of its receptor. Blood 1994; 83:3500-8; PMID:8204877
   PubMed Web of Science ®Google Scholar
• Eberhardt MO, Frank R, Kratje R, Etcheverrigaray M. Identification of two potential receptor-binding sites for hGM-CSF. Brazilian Journal of Chemical Engineering 2003; 20:15-20; http://dx.doi.org/10.1590/S0104-66322003000100004
   Web of Science ®Google Scholar
• Behrens F, Tak PP, Ostergaard M, Stoilov R, Wiland P, Huizinga TW, Berenfus VY, Vladeva S, Rech J, Rubbert-Roth A, et al. MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Ann Rheum Dis 2015; 74:1058-64.
   Web of Science ®Google Scholar
• Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009; 25:1189-91; PMID:19151095; http://dx.doi.org/10.1093/bioinformatics/btp033
   PubMed Web of Science ®Google Scholar
• Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res. 2004; 14:1188-90; PMID:15173120; http://dx.doi.org/10.1101/gr.849004
   PubMed Web of Science ®Google Scholar
• Kleywegt GJ. Dictionaries for heteros. CCP4/ESF-EACBM. Newsletter on Protein Crystallography 1995; 31:45-55
   Google Scholar
• Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 1996; 8:477-86; PMID:9008363; http://dx.doi.org/10.1007/BF00228148
   PubMed Web of Science ®Google Scholar